हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
Assembly Election
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
EMA
EMA News
COVID-19
08 Jul 2022
New Covid wave driven by Omicron subvariants in many countries, warns EMA
A top European agency has warned of a new Covid-19 wave in many countries in Europe The new wave is driven by Omicron subvariants, it said The new wave is driven by BA.4 and BA.5 which are highly-transmissible
COVID-19
18 Mar 2022
Fourth wave: 'Omicron BA2 subvariant spreading fast as nations lift curbs'
After more than a month of decline, Covid-19 cases started to increase around the world last week, the WHO said, with lockdowns in Asia and China`s Jilin province battling to contain an outbreak.
Alkem Laboratories
15 Apr 2016
India's Alkem Labs accused of fudging trial data by German regulator
India`s Alkem Laboratories has been accused by Germany`s health regulator of fudging data on clinical trials of an antibiotic and brain disorder drug, becoming the third Indian firm to be scrutinised since 2014 for suspected manipulation of trial data
Lupin
26 May 2015
Lupin submits fresh studies for two products suspended by EMA
The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.
GVK Biosciences
06 Feb 2015
Swissmedic examines drugs trialled by GVK Biosciences
The Swiss surveillance authority for medicines Friday checked for any corresponding preparations of the 700 generic medicines subjected to clinical trials by India's GVK Biosciences, whose marketing rights were suspended by the European Medicines Agency (EMA).
GVK Biosciences
01 Oct 2014
GVK Bio under scanner of European Drug Regulator
The European Medicines Agency (EMA) has started a review in connection with findings of alleged non-compliance with good clinical practice (GCP) at a facility owned by GVK Biosciences, a city-based Contract Research Organisation.
604075
1
0
Loading...
Trending news
DNA Video
DNA: Anmol Bishnoi Seeks Asylum in the U.S.
DNA Video
DNA: Adani Case - Corruption Allegations Rock Indian Markets
DNA Video
DNA: Were Muslims Stopped from Voting in UP By-Elections?
DNA Video
DNA: Who Did Maharashtra’s Muslims Vote For?
DNA Video
DNA: Russia-Ukraine Conflict Escalates Amid Missile Attacks
DNA Video
DNA: The Beer-Loving Buffalo Stuck in Bihar!
DNA Video
DNA: Akhilesh and the Burqa Controversy in UP Elections
DNA Video
DNA: Is the Opposition to ‘Bantenge To Katenge’ Part of a Larger Plan?
DNA Video
DNA: RSS Master Plan: From Maharashtra to UP
DNA Video
DNA: Bengal’s Waqf Property Controversy
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK